hemophilia 

14265
GRE
单词释义
n.血友病
词根词缀记忆/谐音联想记忆 补充/纠错
对比记忆
haemorrhage n.出血
单词例句
Hemophilia is a genetic disorder that impairs the body's ability to control blood clotting.
血友病是一种遗传性疾病,会损害身体控制血液凝固的能力。
People with hemophilia A lack sufficient amounts of factor VIII, a protein essential for blood clot formation.
血友病A患者缺乏足够的因子VIII,这是一种形成血块所必需的蛋白质。
The symptoms of hemophilia typically include extended bleeding after injury, easy bruising, and joint pain.
血友病的症状通常包括受伤后出血时间延长、容易出现淤青以及关节疼痛。
Treatment for hemophilia often involves replacing the missing blood clotting factors through infusion therapy.
血友病的治疗常常需要通过输液疗法来补充缺失的血液凝固因子。
Hemophilia B, also known as Christmas disease, is caused by a deficiency in factor IX.
血友病B,也称为圣诞节病,是由因子IX缺乏引起的。
It's important for individuals with hemophilia to avoid activities that may result in injuries and subsequent bleeding episodes.
对于血友病患者来说,避免可能造成伤害和随后出血事件的活动非常重要。
Advances in gene therapy hold promise for potentially curing hemophilia in the future.
基因疗法的进步为未来潜在治愈血友病带来了希望。
People with hemophilia should inform their dentists and other healthcare providers about their condition to prevent complications during medical procedures.
血友病患者应告知牙医和其他医疗保健提供者他们的病情,以防止在医疗过程中发生并发症。
In severe cases of hemophilia, even minor bumps can lead to serious internal bleeding.
在血友病的严重情况下,即使轻微的碰撞也可能导致严重的内出血。
Support groups for individuals and families affected by hemophilia provide emotional support and information on managing the condition.
为受血友病影响的个人和家庭设立的支持团体提供了情感支持和管理状况的信息。
Over at the booth of Roche, it launched an initiative by joining hands with stakeholders, including the Chinese Red Cross Foundation and local patient service platform Medi Cover, to provide support from physical, financial and psychological dimensions for children with hemophilia and their families.
在罗氏公司的展台上,它与包括中国红十字基金会和当地患者服务平台Medi Cover在内的利益相关者携手发起了一项倡议,为血友病儿童及其家人提供身体、经济和心理方面的支持。
Hemophilia, an inherited blood clotting disorder, afflicts about 136,000 individuals in China.
血友病是一种遗传性凝血障碍,在中国约有13.6万人患有。
Takeda announced an exclusive agreement last week with Shanghai-based Belief BioMed Inc to accelerate the commercialization of an innovative gene therapy for hemophilia type B in the Chinese market.
武田上周宣布与总部位于上海的Believe BioMed Inc达成独家协议,以加快B型血友病创新基因疗法在中国市场的商业化。
According to Reed, Sanofi has prioritized multiple potentially transformative therapies in areas of high unmet patient need, including Dupixent, the world's first targeted biological agent that has been approved for treating moderate-to-severe atopic dermatitis, Fitusiran and Efanesoctocog alfa (BIVV001) for treatment of hemophilia, Amlitelimab for treatment of inflammatory disorders, Amcenestrant for treatment of breast cancer, RSV Vaccine Nirsevimab, and Tolebrutinib for treatment of multiple sclerosis.
据Reed介绍,赛诺菲已将多种潜在的变革性疗法优先用于患者需求未得到高度满足的领域,包括世界上第一种被批准用于治疗中重度特应性皮炎的靶向生物制剂Dupixent,用于治疗血友病的Fitusiran和Efanesoctocog alfa(BIVV001),用于治疗炎症性疾病的Amlitelimab,Amcenestant治疗乳腺癌症,RSV疫苗Nirsevimab和Tolebrutinib治疗多发性硬化症。
In addition to diabetes, drugs to introduce will cover more disease areas, including obesity, hemophilia, and other chronic diseases.
除了糖尿病药物,我们还将涵盖更多疾病领域,包括肥胖症、血友病以及其他慢性疾病。
At the same time, they will expand their diabetes and hemophilia research funds, and continue to create a high-end international academic communication platform through the Novo Nordisk's Young Scientific Talent Development Program.
同时,他们将扩展糖尿病和血友病研究基金,并通过诺和诺德青年科研人才发展项目,持续打造高端国际学术交流平台。
More efforts are needed in early diagnosis and treatment to help the world's patients suffering from the incurable disease hemophilia, industry experts said.
On Saturday, WuXi AppTec, axa0global provider of research and development and manufacturing services enabling healthcare companies, launched a public welfare seminar on hemophilia, aimed at gathering medical professionals and research experts from home and abroad to explore the latest trends in diagnosis and treatment, and new developments in research and development in the field.
Seventy-five percent patients can hardly get effective treatment, data from the World Federation of Hemophilia showed.
Yang Renchi, head of the China rare blood disease working group under the Holistic Integrative Society of Hematology, said that for hemophilia patients, early diagnosis and treatment lowers bleeding risk.
In recent years, with joint efforts from the industry, the diagnosis and treatment level of hemophilia experienced rapid development.
From traditional clotting factor replacement therapy to innovative gene therapy, the treatment model for hemophilia is constantly developing.
"With the country's economic growth, we have seen rapid growth in hemophilia care in recent years.
Yang said that compared to 30 years ago, the living situation of China's hemophilia patients had improved a lot.
This year, we brought a number of important medicines to the market, including those in the areas of hemophilia and cancer.
The three drugs treat Fabry disease, hemophilia B, and mucopolysaccharidosis, a rare metabolic disorder caused by the absence or malfunctioning of lysosomal enzymes.
Takeda's booth also features five innovative products for hemophilia, including a gene therapy that provides diverse treatment options for patients with various types of hemophilia and distinct treatment requirements.
Liu Yan, head of the hemophilia and rare disease business branch at Takeda China, said, "In China, we're acutely attuned to the unmet needs of hemophilia patients and anticipate expediting the introduction of innovative treatments for Chinese patients through the CIIE. "
未经许可,严禁转发。QQ交流群:688169419
0
0